| __timestamp | Bristol-Myers Squibb Company | Xenon Pharmaceuticals Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 3932000000 | 5903000 |
| Thursday, January 1, 2015 | 3909000000 | 2762000 |
| Friday, January 1, 2016 | 4946000000 | 1114000 |
| Sunday, January 1, 2017 | 6066000000 | 25573000 |
| Monday, January 1, 2018 | 6547000000 | 6000000 |
| Tuesday, January 1, 2019 | 8078000000 | 38845000 |
| Wednesday, January 1, 2020 | 11773000000 | 50523000 |
| Friday, January 1, 2021 | 9940000000 | 75463000 |
| Saturday, January 1, 2022 | 10137000000 | 105767000 |
| Sunday, January 1, 2023 | 10693000000 | 167512000 |
| Monday, January 1, 2024 | 0 |
Data in motion
In the ever-evolving pharmaceutical industry, understanding cost dynamics is crucial. Bristol-Myers Squibb Company, a titan in the field, has seen its cost of revenue grow by approximately 172% from 2014 to 2023. This increase reflects strategic investments and scaling operations. In contrast, Xenon Pharmaceuticals Inc., a smaller player, experienced a staggering 2,736% rise in the same period, albeit from a much smaller base. This growth highlights Xenon's aggressive expansion and innovation efforts.
From 2014 to 2023, Bristol-Myers Squibb's cost of revenue consistently surpassed Xenon's, underscoring its larger market presence. However, Xenon's rapid growth rate suggests a potential shift in the competitive landscape. As we look to the future, these trends offer insights into the strategic directions of these companies and the broader pharmaceutical sector.
Cost of Revenue Comparison: Bristol-Myers Squibb Company vs Regeneron Pharmaceuticals, Inc.
Cost of Revenue Trends: Bristol-Myers Squibb Company vs Biogen Inc.
Cost of Revenue Trends: Bristol-Myers Squibb Company vs Teva Pharmaceutical Industries Limited
Cost of Revenue Trends: Bristol-Myers Squibb Company vs Amphastar Pharmaceuticals, Inc.
Bristol-Myers Squibb Company vs Galapagos NV: Efficiency in Cost of Revenue Explored
Cost of Revenue Comparison: Takeda Pharmaceutical Company Limited vs Xenon Pharmaceuticals Inc.
Exelixis, Inc. vs Xenon Pharmaceuticals Inc.: Efficiency in Cost of Revenue Explored
Cost of Revenue Trends: Perrigo Company plc vs Xenon Pharmaceuticals Inc.
Cost of Revenue Trends: Xenon Pharmaceuticals Inc. vs ACADIA Pharmaceuticals Inc.
Cost of Revenue: Key Insights for Xenon Pharmaceuticals Inc. and Iovance Biotherapeutics, Inc.
Xenon Pharmaceuticals Inc. vs Taro Pharmaceutical Industries Ltd.: Efficiency in Cost of Revenue Explored